Posted by Surbhi on June 29 2026 at 05:04 PM
public
MEK inhibitor breakthroughs in Noonan syndrome — the targeted MAPK pathway therapies demonstrating cardiac function improvement in children with severe hypertrophic cardiomyopathy, alongside Novo...
